Oberweis Asset Management’s iRadimed IRMD Stock Holding History

Oberweis Asset Management’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-19,600	Closed	-$333K	–	139
2016 Q3	$333K	Buy	+19,600	New	+$363K	0.1%	112
2016 Q2	–	Sell	-68,718	Closed	-$1.32M	–	180
2016 Q1	$1.32M	Buy	68,718 +49,500	+258%	+$947K	0.38%	50
2015 Q4	$539K	Buy	19,218 +4,218	+28%	+$119K	0.15%	123
2015 Q3	$365K	Sell	15,000 -3,000	-17%	-$71.8K	0.11%	114
2015 Q2	$419K	Sell	18,000 -2,000	-10%	-$36.5K	0.11%	112
2015 Q1	$305K	Buy	+20,000	New	+$295K	0.09%	144

Other funds holding IRMD

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return

MERSOM

Municipal Employees' Retirement System of Michigan Lansing, Michigan $8.81B AUM 10.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

SIM

Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Oberweis Asset Management's IRMD Position: Q4 2016 in Review

Oberweis Asset Management sold out of iRadimed (IRMD) in Q4 2016, closing a stake of 19,600 shares — an estimated $333K sold.

Oberweis Asset Management first reported a position in IRMD in Q1 2015 and held it in 6 quarters. The position peaked at $1.32M in Q1 2016. 58 funds tracked by Wall St. Rank hold IRMD as of Q4 2016.

Oberweis Asset Management reported no remaining iRadimed position as of Q4 2016 after selling out during the quarter.
Oberweis Asset Management sold 19,600 iRadimed shares in Q4 2016, an estimated $333K.
Oberweis Asset Management first reported a position in iRadimed in Q1 2015 and held it in 6 quarters.
Oberweis Asset Management's iRadimed position peaked at $1.32M in Q1 2016.
58 funds tracked by Wall St. Rank held iRadimed as of Q4 2016.

Based on Oberweis Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.